Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system

Equivalency challenge: Evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model

(2016) Judith A. Smith et al.   GYNECOLOGIC ONCOLOGY

Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance

(2016) Kouichi Shiraishi et al.   JOURNAL OF CONTROLLED RELEASE

Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events

(2016) Sayaka Sasaoka et al.   PLoS One

Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS)

(2016) Saranrat Wittayanukorn et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database

(2015) Yukiya Suzuki et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data

(2015) Ryogo Umetsu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports

(2015) Natsumi Ueda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age

(2015) Junko ABE et al.   International Journal of Medical Sciences

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database

(2011) E. Raschi et al.   ACTA DIABETOLOGICA

Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy

(2011) Ming-Kung Yeh et al.   International Journal of Nanomedicine

Non-pegylated liposomal doxorubicin in metastatic breast cancer patients: A valuable therapeutic option requiring caution

(2010) Daniele Bernardi et al.   BREAST

Quantitative signal detection using spontaneous ADR reporting

(2009) A. Bate et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding

(2008) Fleur Grégoire et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Accelerated Blood Clearance (ABC) Phenomenon Induced by Administration of PEGylated Liposome

(2008) Tatsuhiro ISHIDA et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN